back to top
0.6 C
Europe
Friday, October 31, 2025

АВТОР

RobertGok

884 Новости
0 КОММЕНТАРИЯ

France’s Pernod Ricard reduced annual revenues due to currency fluctuations

France's Pernod Ricard SA, one of the world's largest producers of alcoholic beverages, reduced revenue by 5.5 per cent for the 2025 financial year...

Brown-Forman profit falls, revenue beats expectations

Brown-Forman, maker of Jack Daniel'S whiskey and Woodford Reserve bourbon, has reported a 13% drop in net income for the first quarter of fiscal...

Huawei net profit falls to 37bn yuan, revenue up 4%

Chinese telecoms equipment maker Huawei Technologies Co. cut its net profit in the first half of 2025 by 32% to 37 billion yuan ($5.17...

The largest wind farm in Moldova will be built by a French company

The French group of companies Qair, specialising in the construction of RES facilities, will build in Moldova the country's largest wind power plant (WPP)...

Ryanair to receive 25 Boeing 737 MAX ahead of schedule-O’Leary

Boeing Co. is accelerating deliveries of 737 MAX aircraft to Ryanair Holdings, the Irish budget carrier's chief executive Michael O'Leary said. He also expressed hope...

Vienna Insurance Group increased premiums by 8.7% and profit to €531m

Profits at Vienna Insurance Group (VIG) rose to €531.4m in the first half of 2025, up 10.5 per cent on the same period in...

The number of divorces is growing in Ukraine

Almost half of divorces fall on five regions In the first half of 2025 Ukrainians dissolved at least 38.7 thousand marriages in courts - three...

Nvidia’s quarterly profit up 1.6 times to a record $26.4bn

U.S. graphics processor maker Nvidia Corp. increased its net profit in its fiscal second quarter by 1.6 times, revenue also by 1.6 times, to...

Three Ukrainian citizens detained in Croatia on suspicion of international fraud

Three Ukrainian citizens have been detained in Croatia on suspicion of participating in an international fraud scheme; they were arrested in Dubrovnik on 8...

AbbVie buys depression drug programme from Gilgamesh for $1.2bn

US pharmaceutical company AbbVie Inc. is buying the operations of Gilgamesh Pharmaceuticals Inc. to develop a drug for the treatment of patients with moderate...

Новости